Principles and Terminology for Host-Microbiome-Drug Interactions

Area of Science:

• Microbiology
• Pharmacology
• Systems Biology

Background:

• The interplay between the human microbiome and medical treatments is complex and bidirectional.
• Existing terminology, such as "pharmacomicrobiomics," addresses the microbiome's influence on drug pharmacokinetics and pharmacodynamics.
• A gap exists in describing the reciprocal impact of medical interventions on the microbiome's composition and function.

Purpose of the Study:

• To introduce and define the term "pharmacoecology" to describe the effects of drugs and medical interventions on the microbiome.
• To differentiate "pharmacoecology" from "pharmacomicrobiomics" while highlighting their complementary nature.
• To emphasize the importance of both concepts in evaluating drug safety, efficacy, and overall drug-microbiome interactions.

Main Methods:

• Conceptual framework development.
• Literature review of existing research on drug-microbiome interactions.
• Definition and distinction of proposed terminology.

Main Results:

• Introduction of "pharmacoecology" as a distinct but complementary concept to "pharmacomicrobiomics."
• Demonstration of the bidirectional nature of drug-microbiome interactions.
• Application of these concepts to both antimicrobial and non-antimicrobial medications.

Conclusions:

• "Pharmacomicrobiomics" and "pharmacoecology" are essential, distinct, and complementary terms for understanding drug-microbiome dynamics.
• Both concepts are critical for comprehensive assessment of drug safety, efficacy, and therapeutic outcomes.
• Further research integrating both perspectives will advance personalized medicine and optimize therapeutic strategies.